Signup Crypto ETF Stocks News

Why WeRide Stock Is Skyrocketing Today

WeRide ( NASDAQ: WRD ) is shooting to the moon in Friday's trading. The China-based autonomous driving company's share price was up 81% as of 1 p.m. ET and had been up as much as 146% earlier in the session.WeRide's valuation is surging after artificial intelligence ( AI ) hardware leader Nvidia ...

Source: www.fool.com
February 14, 2025 | 18:14:00
Category: News

What the Options Market Tells Us About NVIDIA - NVIDIA ( NASDAQ:NVDA )

Financial giants have made a conspicuous bearish move on NVIDIA. Our analysis of options history for NVIDIA NVDA revealed 360 unusual trades. Delving into the details, we found 40% of traders were bullish, while 47% showed bearish tendencies.

Source: www.benzinga.com
February 14, 2025 | 18:15:28
Category: News

Broadcom's Options Frenzy: What You Need to Know - Broadcom ( NASDAQ:AVGO )

Financial giants have made a conspicuous bullish move on Broadcom. Our analysis of options history for Broadcom AVGO revealed 88 unusual trades. Delving into the details, we found 54% of traders were bullish, while 32% showed bearish tendencies.

Source: www.benzinga.com
February 14, 2025 | 18:15:34
Category: News

ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Novo Nordisk A/S Investors to Secure Counsel Before Important Deadline in Securities Class Action - NVO - Novo Nordisk ( NYSE:NVO )

NEW YORK, Feb. 14, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Novo Nordisk A/S NVO between November 2, 2022 and December 19, 2024, both dates inclusive ( the "Class Period" ) , of the important March 25, 2025 lead ...

Source: www.benzinga.com
February 14, 2025 | 18:16:00
Category: News

Aramis Biotechnologies and the Biologics Manufacturing Centre Announce a Partnership

Agreement on Formulation and Finish of a Virus-Like Particle Vaccine for Phase 1 and 2 Clinical Trials

Source: www.benzinga.com
February 14, 2025 | 18:17:00
Category: News

Corbus Pharmaceuticals Highlights Data From Its First US-Based Trial Of Lead Cancer Drug Candidate - Corbus Pharmaceuticals ( NASDAQ:CRBP )

CRB-701 shows 4% combined peripheral neuropathy rate across studies, with no dose-limiting toxicities reported in the dose escalation phase. A proactive ocular toxicity protocol in the Western study reduced adverse event rates at 2.7 mg/kg and 3.6 mg/kg compared to the China study

Source: www.benzinga.com
February 14, 2025 | 18:17:49
Category: News

Why Rivian Stock Jumped Friday

Rivian Automotive ( NASDAQ: RIVN ) stock is ending the week on a winning streak. Shares of the electric vehicle ( EV ) maker surged 6.6% higher on Thursday, and as of 1:10 p.m. ET Friday, the stock was up by a further 4.5%.Some of that upward momentum comes from speculation that the U.S. ...

Source: www.fool.com
February 14, 2025 | 18:18:29
Category: News

The Trade Desk ( TTD ) technical analysis - Trade Desk ( NASDAQ:TTD )

Shares of The Trade Desk ( TTD ) blew up after an earnings report. The may have been a capitulation wish could be bullish for the stock. Get two weeks of free access to pro-level trading tools, including news alerts, scanners, and real-time market insights. Shares of The Trade Desk, Inc.

Source: www.benzinga.com
February 14, 2025 | 18:21:35
Category: News

Palo Alto Analysts Optimistic On Revenue Growth, Expanding Market Share - Palo Alto Networks ( NASDAQ:PANW )

Palo Alto Networks reported Q2 revenues of $2.26B, beating consensus of $2.24B. The company continued with its platformization strategy, which exerted pressure on margins. Get real-time earnings alerts before the market moves and access expert analysis that uncovers hidden opportunities in the ...

Source: www.benzinga.com
February 14, 2025 | 18:22:18
Category: News

© Natavest 2025 - 2026